• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偶然分枝杆菌复合体的药敏试验

Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.

作者信息

Welch D F, Kelly M T

出版信息

Antimicrob Agents Chemother. 1979 Jun;15(6):754-7. doi: 10.1128/AAC.15.6.754.

DOI:10.1128/AAC.15.6.754
PMID:475359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC352753/
Abstract

A total of 24 strains of the Mycobacterium fortuitum complex were tested for susceptibility to antimicrobial agents by the disk diffusion and agar dilution techniques. By comparing zones of inhibition obtained with the disk diffusion technique with results of minimal inhibitory concentration determinations, it was shown that disk diffusion results could predict in vitro susceptibility to selected antimicrobial agents. All of 17 strains of M. fortuitum were susceptible to </=1 mug of amikacin per ml. The corresponding average zone of inhibition around a 10-mug amikacin disk was 37 mm. Seven M. chelonei strains were more resistant to amikacin, with minimal inhibitory concentrations ranging from 1 to 32 mug/ml, and the corresponding average zone size was 21 mm. Susceptibility of both M. fortuitum and M. chelonei to tetracycline was variable and none of the M. chelonei strains was inhibited by polymyxin B, whereas M. fortuitum strains consistently had zones of inhibition around the polymyxin disk. It appears that identification to species of the M. fortuitum complex may be of importance with regard to antibiotic susceptibility. Separation of M. fortuitum and M. chelonei was readily accomplished in the present study by the nitrate reduction and 3-day arylsulfatase tests.

摘要

采用纸片扩散法和琼脂稀释法对24株偶然分枝杆菌复合群菌株进行了抗菌药物敏感性测试。通过将纸片扩散法获得的抑菌圈与最低抑菌浓度测定结果进行比较,结果表明纸片扩散法结果能够预测所选抗菌药物的体外敏感性。17株偶然分枝杆菌均对每毫升≤1微克的阿米卡星敏感。在含10微克阿米卡星的纸片周围,相应的平均抑菌圈直径为37毫米。7株龟分枝杆菌对阿米卡星的耐药性更强,最低抑菌浓度范围为1至32微克/毫升,相应的平均抑菌圈大小为21毫米。偶然分枝杆菌和龟分枝杆菌对四环素的敏感性各不相同,龟分枝杆菌菌株均未被多粘菌素B抑制,而偶然分枝杆菌菌株在多粘菌素纸片周围始终有抑菌圈。就抗生素敏感性而言,偶然分枝杆菌复合群的菌种鉴定似乎很重要。在本研究中,通过硝酸盐还原试验和3天芳基硫酸酯酶试验,很容易将偶然分枝杆菌和龟分枝杆菌区分开来。

相似文献

1
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.偶然分枝杆菌复合体的药敏试验
Antimicrob Agents Chemother. 1979 Jun;15(6):754-7. doi: 10.1128/AAC.15.6.754.
2
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.偶然分枝杆菌和龟分枝杆菌对抗菌剂敏感性的纸片扩散试验
Antimicrob Agents Chemother. 1979 Nov;16(5):611-4. doi: 10.1128/AAC.16.5.611.
3
Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.使用多粘菌素和阿米卡星进行纸片扩散试验以区分偶然分枝杆菌和龟分枝杆菌。
J Clin Microbiol. 1982 Dec;16(6):1003-6. doi: 10.1128/jcm.16.6.1003-1006.1982.
4
Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.用于海分枝杆菌和偶然分枝杆菌复合群对磺胺类药物及抗生素药敏试验的琼脂纸片洗脱法
Antimicrob Agents Chemother. 1983 Oct;24(4):486-93. doi: 10.1128/AAC.24.4.486.
5
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.快速生长分枝杆菌:采用肉汤微量稀释法检测对34种抗菌药物的敏感性
Antimicrob Agents Chemother. 1982 Aug;22(2):186-92. doi: 10.1128/AAC.22.2.186.
6
In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.采用纸片扩散法对快速生长分枝杆菌进行体外抗菌药敏试验:挪威偶然分枝杆菌和龟分枝杆菌分离株的耐药模式
APMIS. 1993 Jan;101(1):27-32.
7
In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.偶然分枝杆菌和龟分枝杆菌对阿米卡星的体外敏感性
J Infect Dis. 1978 Mar;137(3):318-21. doi: 10.1093/infdis/137.3.318.
8
Susceptibility of Mycobacterium fortuitum to antibacterial agents as evaluated by disk diffusion and agar dilution methods.
Boll Ist Sieroter Milan. 1983 Nov 30;62(5):402-5.
9
Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.阿米卡星、红霉素和强力霉素对龟分枝杆菌和偶然分枝杆菌的活性。
Tubercle. 1978 Dec;59(4):277-80. doi: 10.1016/0041-3879(78)90005-3.
10
In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.偶然分枝杆菌和龟分枝杆菌对头孢美唑的体外敏感性
Antimicrob Agents Chemother. 1985 Feb;27(2):282-3. doi: 10.1128/AAC.27.2.282.

引用本文的文献

1
Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.阿米卡星和氧氟沙星对偶然分枝杆菌的抗生素后效应。
Antimicrob Agents Chemother. 1993 May;37(5):1001-3. doi: 10.1128/AAC.37.5.1001.
2
Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.用于龟分枝杆菌和偶然分枝杆菌快速药敏试验的Etest评估。
J Clin Microbiol. 1994 Aug;32(8):1846-9. doi: 10.1128/jcm.32.8.1846-1849.1994.
3
In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.偶然分枝杆菌对头孢西丁的体外敏感性
Antimicrob Agents Chemother. 1981 Jan;19(1):205-7. doi: 10.1128/AAC.19.1.205.
4
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.快速生长分枝杆菌:采用肉汤微量稀释法检测对34种抗菌药物的敏感性
Antimicrob Agents Chemother. 1982 Aug;22(2):186-92. doi: 10.1128/AAC.22.2.186.
5
Isolation of Mycobacterium chelonei with the lysis-centrifugation blood culture technique.采用裂解离心血液培养技术分离龟分枝杆菌。
J Clin Microbiol. 1982 Aug;16(2):403-5. doi: 10.1128/jcm.16.2.403-405.1982.
6
Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.用于海分枝杆菌和偶然分枝杆菌复合群对磺胺类药物及抗生素药敏试验的琼脂纸片洗脱法
Antimicrob Agents Chemother. 1983 Oct;24(4):486-93. doi: 10.1128/AAC.24.4.486.
7
Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.使用多粘菌素和阿米卡星进行纸片扩散试验以区分偶然分枝杆菌和龟分枝杆菌。
J Clin Microbiol. 1982 Dec;16(6):1003-6. doi: 10.1128/jcm.16.6.1003-1006.1982.
8
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.偶然分枝杆菌和龟分枝杆菌五个亚组的抗菌药敏性
Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807.
9
In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.偶然分枝杆菌和龟分枝杆菌对头孢美唑的体外敏感性
Antimicrob Agents Chemother. 1985 Feb;27(2):282-3. doi: 10.1128/AAC.27.2.282.
10
Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae.环丙沙星能够区分偶然分枝杆菌的所有三种生物变种与龟分枝杆菌,但吡哌酸不能。
J Clin Microbiol. 1987 Feb;25(2):456-7. doi: 10.1128/jcm.25.2.456-457.1987.

本文引用的文献

1
GRANULOMA OF THE SKIN DUE TO MYCOBACTERIUM FORTUITUM.偶然分枝杆菌所致皮肤肉芽肿
South Med J. 1964 Nov;57:1352-6. doi: 10.1097/00007611-196411000-00019.
2
Antibiotic susceptibility testing by a standardized single disk method.采用标准化单纸片法进行抗生素敏感性试验。
Am J Clin Pathol. 1966 Apr;45(4):493-6.
3
Mycobacterium fortuitum--a human pathogen.偶然分枝杆菌——一种人类病原体。
Ann Intern Med. 1970 Dec;73(6):971-7. doi: 10.7326/0003-4819-73-6-971.
4
Infection caused by Mycobacterium fortuitum.偶然分枝杆菌引起的感染。
Mayo Clin Proc. 1971 Nov;46(11):747-50.
5
Diagnostic key to mycobacteria encountered in clinical laboratories.临床实验室中常见分枝杆菌的诊断要点。
Appl Microbiol. 1968 Jun;16(6):925-31. doi: 10.1128/am.16.6.925-931.1968.
6
The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.偶然分枝杆菌和龟分枝杆菌对人类的致病性:7例报告
Tubercle. 1976 Mar;57(1):49-57. doi: 10.1016/0041-3879(76)90017-9.
7
Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.偶然分枝杆菌复合群中各微生物对抗结核及其他抗菌药物的敏感性。
Antimicrob Agents Chemother. 1977 Aug;12(2):295-7. doi: 10.1128/AAC.12.2.295.
8
In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.偶然分枝杆菌和龟分枝杆菌对阿米卡星的体外敏感性
J Infect Dis. 1978 Mar;137(3):318-21. doi: 10.1093/infdis/137.3.318.
9
Infection of prosthetic arthroplasty by Mycobacterium fortuitum. Two case reports.偶然分枝杆菌所致人工关节置换感染。两例报告。
J Bone Joint Surg Am. 1979 Mar;61(2):300-2.